Congressman Michael McCaul

Representing the 10th District of Texas

Press Releases

Apr 3, 2015 Press Release
AUSTIN, TX – Today, following the announcement by President Obama on the details of the framework for an Iranian nuclear deal, Chairman of the House Committee on Homeland Security, Congressman Michael McCaul (R-TX), released the following statement.
Mar 10, 2015 Press Release
2011 Law Established Voucher Program that Enabled Development of Treatment
AUSTIN, TX – Today the Food and Drug Administration announced it has approved the first pediatric cancer drug due to the voucher program that became law under the Creating Hope Act. The drug, Unituxin, developed by United Therapeutics, designed to treat neuroblastoma, is only the third third drug to receive initial FDA approval for a pediatric cancer in the last 20 years. The Creating Hope Act was signed into law in 2011, and was sponsored by Representative Michael McCaul, Representative G.K. Butterfield, and Representative Chris Van Hollen.
Issues:
Mar 3, 2015 Press Release
WASHINGTON, DC – Today following Israeli Prime Minister Benjamin Netanyahu’s address to a joint meeting of Congress, Congressman Michael McCaul released the following statement.
Feb 17, 2015 Press Release
AUSTIN, TX – This morning, following the announcement that a U.S. federal district court has issued a preliminary injunction blocking President Obama’s unconstitutional executive amnesty, Congressman McCaul released the following statement:
Feb 12, 2015 Press Release
McCaul Introduces Bill to Improve Access to Potentially Lifesaving Drugs for Sick Patients The Andrea Sloan Compassionate Use Reform and Enhancement Act
WASHINGTON, DC – Today, U.S. Representative Michael McCaul (R-TX) introduced H.R. 909, the Andrea Sloan Compassionate Use Reform and Enhancement (CURE) Act, which would make important reforms to the Food and Drug Administration’s (FDA) expanded access ("compassionate use") process, by ensuring seriously ill patients have the right to know the compassionate use policies of pharmaceutical companies developing the most innovative treatments. He was joined by Representative G.K. Butterfield (D-NC), Rep. Michael Burgess (R-TX), Rep. Doris Matsui (D-CA), Representative Morgan Griffith (R-VA), and Representative Leonard Lance (R-NJ). The bill is named after Andrea Sloan, an Austin resident who died on New Year's Day 2014 after being denied access to a potentially lifesaving drugs to treat her seven-year battle with ovarian cancer.
Issues:
Feb 6, 2015 Press Release
AUSTIN, TX – Today following the announcement that the U.S. Army will award Purple Hearts to the victims of the 2009 terrorist attack on Ft. Hood, Congressman Michael McCaul released the following statement:
Feb 2, 2015 Press Release
WASHINGTON, DC – Today following the release of President Obama’s FY 2016 budget proposal, Congressman McCaul released the following statement:
Issues:
Jan 27, 2015 Press Release
WASHINGTON, DC – Today following the announcement that the Energy and Commerce Committee has included the the Andrea Sloan Cure Act, which Congressman McCaul authored, into its discussion document for the 21st Century Cures Act, McCaul released the following statement.
Jan 23, 2015 Press Release
WASHINGTON, DC– This week Congressman Michael McCaul (TX-10) and Congresswoman Kyrsten Sinema (AZ-09) introduced the “No Raise for Congress” Act today to end automatic pay increases for members of Congress.
Jan 20, 2015 Press Release
WASHINGTON, DC – Tonight following the State of the Union Address by President Obama, Congressman McCaul (R-TX) released the following statement:

Pages